John D Abernathy's Net Worth

$7.42 Million

Estimate Recalculated Jan 3, 2025 04:05PM EST

Who is John D Abernathy?

John D Abernathy has an estimated net worth of $7.42 Million. This is based on reported shares across multiple companies, which include STERLING CONSTRUCTION CO INC, PAR PHARMACEUTICAL COMPANIES, INC., and Neuro-Hitech, Inc..

SEC CIK

John D Abernathy's CIK is 0001017996

Past Insider Trading and Trends

2007 was John D Abernathy's most active year for acquiring shares with 14 total transactions. John D Abernathy's most active month to acquire stocks was the month of December. 2007 was John D Abernathy's most active year for disposing of shares, totalling 193 transactions. John D Abernathy's most active month to dispose stocks was the month of December. 2004 saw John D Abernathy paying a total of $192,939.00 for 34,996 shares, this is the most they've acquired in one year. In 2011 John D Abernathy cashed out on 20,000 shares for a total of $300,081.90, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STERLING CONSTRUCTION CO INC (STRL) Snapshot price: $109.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.14%
4.97K
—
—
54.03K
May 9
Form 4/A
+11.74%
5.16K
—
—
49.05K
May 8
Form 4/A
+12.14%
5.33K
—
—
49.23K
May 8
Form 4
+11.74%
5.16K
—
—
49.05K
May 8
Form 4
+8.44%
3.42K
—
—
43.9K
May 6
Form 4
-3.89%
-1.64K
$15.05
-$24,651.90
40.48K
Mar 22
Form 4
-30.36%
-18.36K
$15.00
-$275,430.00
42.12K
Mar 21
Form 4
+9.01%
5K
$6.87
$34,350.00
60.48K
Dec 3
Form 4
+6.01%
3.15K
—
—
55.48K
May 6
Form 4
-8.72%
-5.00K
$17.66
-$88,275.00
52.33K
Jun 3
Form 4
+5.13%
2.8K
—
—
57.33K
May 6
Form 4
+54.19%
19.17K
$1.30
$24,877.50
54.53K
Nov 7
Form 4
+7.82%
2.56K
—
—
35.37K
May 12
Form 4
+10.07%
3K
$0.84
$2,532.00
32.8K
Apr 25
Form 4
+5.67%
1.6K
—
—
29.8K
May 7
Form 4
-1.92%
-200.00
$21.55
-$4,310.00
10.2K
Scheduled
Feb 12
Form 4
+1.96%
200
$11.05
-$199,234.00
10.4K
Scheduled
Feb 12
Form 4
—
0
$10.97
-$201,756.90
10.2K
Scheduled
Feb 5
Form 4
-8.11%
-1.05K
$20.68
-$21,748.53
10.2K
Scheduled
Jan 29
Form 4
+27.17%
2.77K
$10.65
-$138,808.64
12.97K
Scheduled
Jan 29
Form 4
-0.03%
-3.00
$20.68
-$62.04
10.2K
Scheduled
Jan 22
Form 4
+0.03%
3
$10.62
-$194,828.74
10.21K
Scheduled
Jan 22
Form 4
-7.69%
-850.00
$19.59
-$16,655.50
10.2K
Scheduled
Jan 16
Form 4
-31.36%
-5.05K
$19.09
-$96,416.94
11.05K
Scheduled
Jan 16
Form 4
+57.83%
5.9K
$9.77
-$67,747.97
16.1K
Scheduled
Jan 16
Form 4
+13.42%
1.21K
—
—
10.2K
May 10
Form 4
+50.03%
3K
$1.22
$3,657.00
9K
Jan 20
Form 4
-42.32%
-4.40K
$21.50
-$94,600.00
6K
Sep 15
Form 4
-71.12%
-25.60K
$21.80
-$557,956.00
10.4K
Sep 15
Form 4
—
0
—
—
0
May 19
Form 4
+9.09%
3K
$3.38
$10,125.00
36K
Mar 31
Form 4/A
+10.00%
3K
$2.75
$8,250.00
33K
Jan 28
Form 4
+16.19%
18K
$2.75
$49,489.00
129.16K
Jan 28
No matching records found

PAR PHARMACEUTICAL COMPANIES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jan 7
Form 4
+76.92%
5K
$18.25
$91,236.50
11.5K
Oct 3
Form 4
+50.00%
2.5K
—
—
7.5K
Jan 31
Form 4
+100.00%
2.5K
—
—
5K
Jan 9
Form 4
∞
2.5K
—
—
2.5K
Jan 6
Form 4
+160.00%
4K
$33.80
$135,200.00
6.5K
May 6
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
No matching records found

Neuro-Hitech, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.58%
150K
—
—
583.77K
Jun 24
Form 4
+1,184.45%
400K
$0.25
$100,000.00
433.77K
Jun 6
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found